...
首页> 外文期刊>Journal of cellular and molecular medicine. >Renal cortex remodeling in nitric oxide deficient rats treated with enalapril.
【24h】

Renal cortex remodeling in nitric oxide deficient rats treated with enalapril.

机译:依那普利治疗一氧化氮缺乏大鼠的肾皮质重构。

获取原文
获取原文并翻译 | 示例
           

摘要

The kidney NO synthase is one of the most important renal controlling systems. This paper aims the quantification of renal cortical components involved in blood pressure regulation under NOs blockade. Spontaneous hypertensive rats (SHRs) are submitted to chronic blockade of NOs by L-nitro-arginine-methyl-ester (L-NAME) and an ACE inhibitor (enalapril) in comparison with the normotensive Wistar rats. Twenty SHRs and 5 Wistar rats were divided in 5 groups and observed for 21 days for blood pressure (BP) and serum creatinine: control Wistar (5) (C-W), control SHR (5) (C-SHR), L-SHR (5)--received L-NAME 30 mg/kg/day, L+E-SHR (5)--received L-NAME and Enalapril maleate 15 mg/kg/day, E-SHR (5)--received Enalapril maleate. A quantitative morphometric study (glomerular density, QA[gl], interstitium volume density, Vv[i], tubular surface and length densities, Sv[t] and Lv[t]) were performed at the end. The BP reached 226+/-15 mmHg in L-SHR group. The BP difference between the L-SHR and the C-SHR groups was significant from the first week while the E-SHR group became significant from the second week. At the end of the experiment the BP of the E-SHR group was similar to the BP in the C-W group. The QA[gl] was similar among C-SHR, L-SHR and L+E-SHR groups and no difference was found between E-SHR and C-W groups. In the L-SHRs serum creatinine was greatly increased, and microscopy showed thickening of arteriolar tunica media with an increase of the wall-to-lumen ratio, perivascular fibrosis, inflammatory infiltrated, tubular atrophy and interstitial fibrosis with focal segmental glomerulosclerosis. The use of enalapril was not completely efficient in reducing BP and morphological injury when the hypertension of SHRs was increased with the NOs blockade suggesting that NO deficiency-induced hypertension is not entirely mediated by the RAAS.
机译:肾脏NO合酶是最重要的肾脏控制系统之一。本文旨在量化NOs阻断下参与血压调节的肾皮质成分的定量。与正常血压的Wistar大鼠相比,自发性高血压大鼠(SHRs)受到L-硝基精氨酸甲酯(L-NAME)和ACE抑制剂(依那普利)的NO慢性阻断。将20只SHR和5只Wistar大鼠分为5组,并观察21天的血压(BP)和血清肌酐:对照组Wistar(5)(CW),对照组SHR(5)(C-SHR),L-SHR( 5)-接受L-NAME 30 mg / kg /天,L + E-SHR(5)-接受L-NAME和马来酸依那普利15 mg / kg / day,E-SHR(5)-接受马来酸Enalapril 。最后进行了定量形态学研究(肾小球密度,QA [gl],间质体积密度,Vv [i],管状表面和长度密度,Sv [t]和Lv [t])。 L-SHR组的血压达到226 +/- 15 mmHg。 L-SHR组和C-SHR组之间的BP差异从第一周开始就显着,而E-SHR组从第二周开始就变得显着。在实验结束时,E-SHR组的血压与C-W组的血压相似。 C-SHR,L-SHR和L + E-SHR组之间的QA [gl]相似,E-SHR和C-W组之间没有发现差异。在L-SHRs中,血清肌酐大大增加,并且显微镜检查显示小动脉中膜增厚,壁-腔比增加,血管周围纤维化,炎性浸润,肾小管萎缩和间质纤维化伴局灶性节段性肾小球硬化。当通过NOs阻断增加SHRs的高血压时,依那普利的使用并不完全有效地降低BP和形态损伤,这表明NO缺乏诱导的高血压并非完全由RAAS介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号